US Diagnostic Imaging: Export Sales (2026)

The United States dominates the global diagnostic imaging equipment market. GE HealthCare alone generated $9.25 billion in imaging segment revenue in 2025, a 4.4% year-over-year increase. Add Hologic, Carestream, Varex Imaging, and dozens of specialized OEMs building MRI coils, CT detectors, ultrasound probes, and digital X-ray panels, and you have a sector with massive international demand and an outdated playbook for reaching buyers. AI-powered outbound is the pipeline channel that finally matches the scale of the opportunity.

The US Diagnostic Imaging Sector: Enormous Output, Narrow Export Channels

The global diagnostic imaging equipment market reached $50.12 billion in 2025 and is projected to hit $76.69 billion by 2034, growing at a 4.84% CAGR. North America holds 44% of that market, with the US alone accounting for $16.54 billion in domestic diagnostic imaging activity.

On the export side, US manufacturers shipped an estimated $492 million in X-ray, CT, and MRI equipment (HS code 9022) in 2024, plus $79 million in ultrasonic scanning apparatus. The top destinations for US medical equipment exports overall include Canada ($8.2 billion), Germany ($3.68 billion), Japan ($2.52 billion), the United Kingdom ($2.1 billion), and South Korea ($1.05 billion). These numbers span all medical equipment categories, but diagnostic imaging follows the same geographic pattern: Western Europe, East Asia, and the Anglosphere absorb the majority of US-made imaging systems.

The structural issue is who controls access to those buyers. Major OEMs like GE HealthCare, Hologic, and Varex Imaging maintain their own global sales teams. But the mid-market, the companies making specialized detectors, imaging software, replacement tubes, portable ultrasound units, contrast media delivery systems, and AI-enhanced diagnostic tools, typically lacks the infrastructure to reach hospital procurement teams in Frankfurt, Riyadh, or Seoul. These manufacturers depend on a small number of channels that are all showing diminishing returns.

Why Traditional Channels Are Failing US Imaging Exporters

American diagnostic imaging manufacturers have relied on the same sales channels for decades. Every one of them is becoming more expensive, more crowded, and less effective at building consistent international pipeline.

RSNA: The Gold Standard That Costs Gold

The Radiological Society of North America (RSNA) annual meeting is the largest radiology trade show in the world. RSNA 2025 featured more than 660 exhibitors across 415,000 square feet of show floor at McCormick Place in Chicago, including a dedicated 45,000-square-foot AI Showcase with over 200 companies demonstrating machine learning solutions.

RSNA is where purchasing decisions worth billions get discussed. But the economics for mid-size imaging companies are brutal. A 200-square-foot inline booth starts at roughly $10,000 in space rental alone. Factor in booth design, construction, shipping, staffing, travel, lodging, and pre-show marketing, and a modest RSNA presence runs $40,000 to $80,000. Larger island exhibits can exceed $200,000. You get four days of foot traffic per year. The other 361 days, your competitors are in the inbox of every radiology director you wanted to meet.

MEDICA Dusseldorf: Massive Scale, Massive Noise

MEDICA is the world’s largest medical trade fair: over 5,000 exhibitors from 72 countries, more than 80,000 visitors, four days each November in Dusseldorf. For US imaging manufacturers targeting European, Middle Eastern, and African buyers, MEDICA is considered mandatory. But with 5,000 exhibitors competing for attention, standing out requires a booth investment of $25,000 to $75,000 at the low end, with major exhibitors spending well into six figures.

The math is straightforward. You spend $50,000+ for a handful of qualified conversations, then wait 12 months to do it again while procurement teams make decisions between shows.

ECR: Growing but Geographically Limited

The European Congress of Radiology (ECR) drew 20,522 participants from 131 countries in 2025, a 9% increase over the prior year, with 241 exhibitors. ECR offers strong access to European radiologists and imaging directors but covers a single region. If your target market includes the Gulf states, Southeast Asia, or Latin America, ECR does not help.

Arab Health: Regional Access, Regional Limits

Arab Health in Dubai is the gateway to Middle Eastern and North African healthcare procurement. The show attracts roughly 1,500 exhibitors and upwards of 30,000 visitors. But it runs just four days in January, covers one region, and requires the same heavy logistical investment as every other major medical fair.

GPO Networks: Gatekeepers That Compress Margins

In the domestic US market, Group Purchasing Organizations control a massive share of hospital procurement. For imaging equipment, this means GPO contracts dictate which MRI systems, CT scanners, and X-ray panels hospitals can purchase at negotiated rates. The problem for mid-size imaging companies is structural: GPOs tend to bundle contracts with large, diversified manufacturers, making it extremely difficult for specialized companies to break in.

Distributors typically claim 30% to 50% of the end price, and GPO administrative fees continue to rise. A Government Accountability Office study found that GPO contracts did not always reduce costs and in some cases increased them by as much as 37%. For international sales, the equivalent structure is exclusive distributor agreements, which create the same margin compression without giving you any direct relationship with the hospital or clinic making the purchase.

Field Representatives: High Cost, Low Coverage

A qualified medical imaging sales representative in the United States costs $150,000 to $275,000 annually in total compensation. That person can cover one or two metropolitan areas effectively. Reaching radiology directors, imaging department managers, and hospital procurement committees across Europe, Asia, the Middle East, and Latin America requires either a very large team or accepting that most markets stay unserved.

The complexity of imaging sales compounds the problem. Selling an MRI system or CT scanner involves conversations with radiologists, medical physicists, IT departments (for PACS integration), facilities teams (for siting and installation), and procurement. Finding field reps who understand all of this and speak the local language is rare and expensive.

Three Market Shifts That Make AI Outbound Critical Now

1. AI-Powered Imaging Is Rewriting the Competitive Landscape

The radiology AI market reached $760 million in 2025 and is projected to hit $2.27 billion by 2030, growing at 24.5% CAGR. GE HealthCare’s Edison platform, Philips’ AI-integrated Verida spectral CT system, and Siemens Healthineers’ AI-Rad Companion are reshaping what buyers expect from imaging equipment. Hospitals are not just buying hardware anymore. They want integrated AI analytics, cloud connectivity, and workflow automation.

This shift creates opportunity for US companies building AI-enhanced imaging components and software, but only if those companies can reach the radiology directors and hospital CIOs evaluating these solutions. Waiting for RSNA or hoping a distributor mentions your product is not a strategy. It is a gamble.

2. Emerging Market Hospital Expansion

Healthcare infrastructure spending across Asia, the Middle East, and Latin America is driving massive demand for diagnostic imaging equipment. The Asia-Pacific medical imaging market is growing at roughly 9% annually. Saudi Arabia’s Vision 2030, India’s Ayushman Bharat program, and hospital construction booms across Southeast Asia all require CT scanners, MRI systems, ultrasound units, and digital X-ray panels.

Procurement teams in these regions actively prefer FDA-cleared US-made equipment for its safety standards and clinical validation. But they need to know your company exists. A radiology department director in Jakarta or Jeddah is not flying to Chicago for RSNA. They are responding to the outbound message that lands in their inbox with a relevant, personalized value proposition.

3. Supply Chain Diversification Demand

The semiconductor shortages and logistics disruptions of 2020 to 2023 taught hospital systems that concentrated supply chains break. Imaging equipment manufacturers worldwide are actively qualifying second and third sources for X-ray tubes, flat-panel detectors, gradient coils, and imaging software. US manufacturers, with their reputation for quality and FDA oversight, are natural beneficiaries of this shift. But qualification requires conversation, and conversation requires outreach.

How AI-Powered Outbound Works for Diagnostic Imaging Exporters

Traditional outbound for medical imaging was always constrained by scale and specificity. You could not personalize at volume because every hospital, every radiology department, every procurement committee has different needs, installed equipment, and regulatory requirements.

AI-powered outbound changes that equation entirely. Here is what the process looks like when built for diagnostic imaging exporters:

Buyer identification and segmentation. AI systems pull from hospital databases, procurement records, regulatory filings, and professional networks to build targeted lists of radiology directors, imaging department managers, biomedical engineers, and procurement officers at hospitals and imaging centers worldwide. The targeting is specific: hospitals running aging GE or Siemens equipment due for replacement, facilities expanding imaging capacity, or procurement teams actively evaluating new vendors.

Hyper-personalized messaging at scale. Each outreach message references the prospect’s specific context: the imaging modalities they use, the regulatory environment they operate in, the clinical challenges they face, the equipment lifecycle stage of their current install base. This is not mail merge with a first name. It is contextual relevance that demonstrates you understand their world.

Multi-channel delivery. Outreach reaches prospects through email, LinkedIn, and other professional channels, timed for optimal engagement based on the recipient’s timezone and professional patterns.

Automated follow-up sequences. Imaging equipment sales cycles are long, often 6 to 18 months for capital equipment. AI-powered systems maintain persistent, relevant follow-up without requiring a sales rep to remember every prospect. When a radiology director opens your third message about spectral CT capabilities, the system knows and adjusts the next touchpoint accordingly.

For a detailed look at how this engine operates, visit our growth engine overview or see how it works in practice.

The Cost Comparison: AI Outbound vs. Legacy Channels

The economics are not close.

Channel	Cost Per Qualified Lead	Coverage	Frequency
RSNA booth (mid-size)	$300 to $900+	4 days/year, one venue	Annual
MEDICA exhibit	$400 to $900+	4 days/year, one venue	Annual
ECR booth	$300 to $700+	4 days/year, one venue	Annual
Arab Health exhibit	$350 to $800+	4 days/year, one venue	Annual
GPO/Distributor network	Margin loss of 30-50%	Limited geographies	Ongoing but passive
Field sales rep	$500 to $1,200+	1-2 markets per rep	Ongoing but limited
AI-powered outbound	$150 to $300	Global, 365 days/year	Continuous

A mid-size US imaging manufacturer spending $200,000 annually on two trade shows and one field rep in Europe reaches perhaps 100 to 150 qualified contacts. The same budget deployed through AI-powered outbound reaches thousands of verified decision-makers across every target market, every month, with personalized messaging that references their specific clinical and procurement context.

Who Should Be Using AI Outbound in Diagnostic Imaging

This approach is built for US manufacturers in positions like these:

• Specialized OEMs making X-ray tubes, flat-panel detectors, MRI coils, CT components, or ultrasound transducers who sell to larger system integrators and hospitals globally
• AI imaging software companies whose FDA-cleared algorithms need to reach radiology directors and hospital CIOs evaluating new diagnostic tools
• Portable and point-of-care ultrasound manufacturers targeting clinics, rural hospitals, and emergency departments in emerging markets
• Refurbished imaging equipment dealers who serve cost-sensitive markets in Latin America, Africa, and Southeast Asia
• Contrast media and consumable suppliers who need consistent pipeline beyond GPO contracts
• Service and maintenance companies expanding into international markets where installed imaging equipment bases are growing

If your company builds, distributes, or services diagnostic imaging equipment and your international pipeline depends on trade shows, distributors, or a handful of field reps, the math no longer works. The companies capturing the next wave of global imaging demand will be the ones reaching buyers directly, continuously, and at scale.

Frequently Asked Questions

How does AI outbound handle the complex buying committees in diagnostic imaging?

Diagnostic imaging purchases involve radiologists, medical physicists, IT teams, procurement officers, and hospital administrators. AI-powered outbound maps these stakeholders within each target organization and sequences messaging to each role with relevant content: clinical performance data for radiologists, integration specifications for IT directors, total cost of ownership for procurement, and ROI models for administrators. This multi-threaded approach mirrors how enterprise sales teams operate but executes at a scale no field team can match.

Does this work for regulatory-heavy markets like the EU or Japan?

Yes. The outreach is built with regulatory context baked in. Messages to European hospital procurement teams reference CE marking and MDR compliance. Outreach to Japanese buyers addresses PMDA requirements. This regulatory fluency is part of what separates AI-powered outbound from generic email blasts. Every message reflects the buyer’s regulatory reality, which immediately establishes credibility. For more on how we tailor by market, contact our team.

Can AI outbound replace trade shows entirely?

Not necessarily, and that is not the goal. Trade shows like RSNA and MEDICA remain valuable for product demonstrations, hands-on evaluations, and relationship deepening. What AI outbound replaces is the dependency on trade shows as your primary pipeline source. The strongest approach is using outbound to generate and warm leads year-round, then using trade show meetings to accelerate deals already in motion. Your booth becomes a closing tool, not a cold prospecting tool.

What kind of results should a US imaging exporter expect?

Results vary by product category, target market, and price point. Capital equipment like MRI and CT systems has longer sales cycles (6 to 18 months) but higher deal values. Components, consumables, and software typically convert faster. Across our B2B manufacturing clients, AI-powered outbound consistently delivers qualified leads at $150 to $300 per lead, compared to $500 to $1,200+ through field sales and $300 to $900+ through trade fair exhibiting. Learn more about our approach or explore how US manufacturing exporters and US medical device companies are already making this shift.

The Window Is Open

The diagnostic imaging equipment market is growing at nearly 5% annually. AI integration is reshaping what buyers demand. Emerging markets are building hospitals and imaging centers at unprecedented rates. Supply chain diversification is creating openings for US manufacturers who have never had access to these buyers before.

But growth in demand does not automatically translate to growth in your pipeline. The manufacturers who capture this opportunity will be the ones who build continuous, scalable, AI-powered outbound systems that reach radiology directors, procurement teams, and hospital administrators across every target market, every week of the year.

Trade fairs give you four days. Field reps give you one or two markets. AI-powered outbound gives you the world, 365 days a year, at a fraction of the cost.

See how it works or get in touch to discuss what this looks like for your imaging business.